Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05477485 · ClinicalTrials.gov registry record · NA
Antiretroviral Improvement Among Medicaid Enrollees
A NA study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05477485 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 4 participants.
The verdict
NCT05477485, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study will evaluate whether a new program will affect how often human immunodeficiency virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program improves the health of people living with HIV.
Interventions
- BEHAVIORAL Experimental: AIMS program - patient
- OTHER No Intervention/Usual care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2023-04-27 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05477485
The ClinicalTrials.gov registry entry for NCT05477485 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Experimental: AIMS program - patient is the first listed.
NCT05477485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05477485 about?
NCT05477485 is a clinical study titled "Antiretroviral Improvement Among Medicaid Enrollees". This study will evaluate whether a new program will affect how often human immunodeficiency virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program improves the health of people living with HIV.
What is the current status of trial NCT05477485?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2023-04-27. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT05477485?
The interventions under investigation include: Experimental: AIMS program - patient (BEHAVIORAL), No Intervention/Usual care (OTHER).
Who is sponsoring clinical trial NCT05477485?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.